Essential Hypertension Clinical Trial
Official title:
The Effects of Social Support and Oxytocin Administration on Physiological Stress Reactivity in Essential Hypertension
To test a psychopharmacological intervention strategy which may provide new insights into the mechanisms underlying the physiological hyperreactivity to stress observed in hypertension, we plan to test the effects of the neuropeptide oxytocin and social support on the neurobiological and psychological responsiveness to social stress. The study population for this project consists of 80 hypertensive and 80 normotensive non-smoking medication-free men. We expect exogenous oxytocin administration to enable hypertensives to effectively take advantage of the provided social support. Thereby, oxytocin may enhance the effect of social support on reducing the previously observed physiological hyperreactivity to stress in essential hypertensives.
Background
Data on psychobiological stress reactivity in essential hypertension demonstrated
physiological hyperreactivity to acute psychosocial stress in hypertensives as compared to
normotensive controls in terms of sympathetic nervous system and
hypothalamus-pituitary-adrenal axis activity, blood lipids, and coagulation activity.
Moreover, we found lower perceived social support in hypertensives as compared to
normotensives, with the highest physiological stress responses in hypertensives with low
perceived social support.. In addition, the collaborating group of Prof. Heinrichs
demonstrated that OT and social support interact to reduce neuroendocrine responses to stress
in normotensive individuals. Given these findings and given the aforementioned hypothesized
role for OT in physiological stress reactivity, particularly in hypertension, it seems
promising to investigate the combined effects of OT and social support provision on
physiological stress reactivity in essential hypertensives as compared to normotensives.
Objective
The proposed project will provide new information on neuroendocrine mechanisms underlying the
observed physiological hyperreactivity to stress in essential hypertension. Moreover, stress
reactivity of intermediate biological risk factors has not yet been investigated in
experiments studying the effects of the acutely provided social support, either in healthy
individuals or in hypertensives. The results of this project may provide important
information for the development of effective interdisciplinary prevention and intervention
strategies for essential hypertension
Methods
The methodological approach of social stress induction by the TSST used in our previous
hypertension study will be translated to the planned project and we will repeatedly collect
blood and saliva samples to measure neuroendocrine reactivity in terms of cortisol,
epinephrine, and norepinephrine, as well as continuously measuring of heart rate and blood
pressure. Blood pressure will be measured at each sampling timepoint as well as twice during
the TSST (during the speech and during mental arithmetics). As our recent findings suggest
strong associations between social support and heightened coagulation activity in healthy
subjects before and after social stress, and as we found higher lipid and coagulation
reactivity to psychosocial stress in hypertensives with catecholamine stress changes
predicting elevated lipid stress reactivity, we plan to additionally measure biological risk
factors for CHD.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03708601 -
Prognostic Risk of Patients With Essential Hypertension for Cardiovascular Events (PROSPECT)
|
||
Not yet recruiting |
NCT05503953 -
Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS
|
Phase 3 | |
Recruiting |
NCT05526703 -
Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy
|
Phase 3 | |
Completed |
NCT06395194 -
Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension
|
Phase 3 | |
Not yet recruiting |
NCT06418074 -
Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity
|
N/A | |
Completed |
NCT02890173 -
Study of CS-3150 in Patients With Essential Hypertension
|
Phase 3 | |
Withdrawn |
NCT02096939 -
Microvascular Function in Primary Aldosteronism
|
N/A | |
Completed |
NCT02944734 -
Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension
|
Phase 2 | |
Recruiting |
NCT01956786 -
Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine
|
Phase 2/Phase 3 | |
Completed |
NCT02553512 -
Helius in Hypertension-I: The UK Hypertension Registry
|
N/A | |
Completed |
NCT01198249 -
Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension
|
Phase 1 | |
Completed |
NCT01001572 -
Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension
|
Phase 3 | |
Recruiting |
NCT00380289 -
Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension
|
N/A | |
Completed |
NCT00139698 -
Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
|
Phase 3 | |
Completed |
NCT00288184 -
Uric Acid in Essential Hypertension in Children
|
Phase 2 | |
Completed |
NCT01289886 -
Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects
|
Phase 1 | |
Not yet recruiting |
NCT06041529 -
Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension
|
Phase 4 | |
Completed |
NCT04470830 -
A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South Korea
|
||
Completed |
NCT00758524 -
A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension
|
Phase 2 | |
Recruiting |
NCT05109013 -
Juvenile Essential Arterial Hypertension and Vascular Function
|